Xiong H, Wojtowicz J M, Baskys A
Department of Physiology, University of Toronto, ON, Canada.
Can J Physiol Pharmacol. 1995 Aug;73(8):1194-7. doi: 10.1139/y95-170.
Adenosine is a potent inhibitory modulator in the brain. It suppresses glutamatergic synaptic transmission and possibly acts as a brain endogenous neuroprotective agent. In this study we have examined the effects of a clinically used porcine brain tissue hydrolysate, Cerebrolysin, on synaptic transmission in the CA1 area of rat hippocampal slices. A major effect of the drug at doses approximating those administered clinically to demented patients was a depression of synaptic transmission at the Schaffer collateral-commissural pathway in CA1. Detailed analysis showed that the inhibition is presynaptic and can be reduced by low doses of a specific blocker of adenosine A1 receptors, 8-cyclopentyltheophylline. Because Cerebrolysin does not contain a detectable amount of adenosine, the effect on adenosine A1 receptors must be indirect, perhaps by release of the endogenous agonist. This action of Cerebrolysin is consistent with a putative neuroprotective action underlying its clinical usage.
腺苷是大脑中一种强效的抑制性调节剂。它抑制谷氨酸能突触传递,并可能作为一种脑内源性神经保护剂发挥作用。在本研究中,我们检测了临床使用的猪脑组织水解物脑蛋白水解物对大鼠海马切片CA1区突触传递的影响。该药物在接近临床给予痴呆患者剂量时的主要作用是抑制CA1区Schaffer侧支-连合通路的突触传递。详细分析表明,这种抑制作用是突触前的,并且可以被低剂量的腺苷A1受体特异性阻滞剂8-环戊基茶碱所减弱。由于脑蛋白水解物不含可检测到的腺苷量,其对腺苷A1受体的作用必定是间接的,可能是通过内源性激动剂的释放。脑蛋白水解物的这一作用与其临床应用中潜在的神经保护作用相一致。